PACS (PACS Group, Inc.) Stock Analysis - AI Report

PACS Group, Inc. (PACS) is a publicly traded Financial Services sector company. As of May 21, 2026, PACS trades at $37.00 with a market cap of $5.83B and a P/E ratio of 29.72. PACS moved +0.53% today. Year to date, PACS is -6.97%; over the trailing twelve months it is +251.04%. Its 52-week range spans $7.50 to $43.92. Analyst consensus is strong buy with an average price target of $48.80. Rallies surfaces PACS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on PACS?

Rallies AI research for PACS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

PACS Key Metrics

Key financial metrics for PACS
MetricValue
Price$37.00
Market Cap$5.83B
P/E Ratio29.72
EPS$1.23
Dividend Yield0.00%
52-Week High$43.92
52-Week Low$7.50
Volume0
Avg Volume0
Revenue (TTM)$5.29B
Net Income$191.46M
Gross Margin0.00%

Latest PACS News

Recent PACS Insider Trades

  • MITCHELL JOHN TODD sold 24.09K (~$892.25K) on May 18, 2026.
  • MITCHELL JOHN TODD sold 3.30K (~$125.44K) on May 18, 2026.
  • MITCHELL JOHN TODD sold 45.95K (~$1.74M) on May 15, 2026.

PACS Analyst Consensus

5 analysts cover PACS: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.80.

Common questions about PACS

What is the AI research view on PACS?
Rallies AI research for PACS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for PACS?
Rallies AI research for PACS combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is PACS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PACS. It does not provide personalized investment advice.
PACS

PACS